Add to ORKGCost-effectiveness analysis of applying the Cholesterol and Recurrent Events (CARE) study protocol in Hong Kong Objective. To determine the cost-effectiveness of secondary prevention with pravastatin in Hong Kong patients with coronary heart disease and average cholesterol levels. Design. Cost-effectiveness analysis based on published results of the CARE study. Patients. Men and women post–myocardial infarction with average cholesterol levels. Main outcome measures. Cost-effectiveness analysis: cost per life saved, cost per fatal or non-fatal coronary event prevented, cost per procedure prevented, and cost per fatal or non-fatal stroke prevented. Cost-utility analysis: gross cost and net cost per quality-adjusted life year gaine
Background: The Mediterranean-style diet (MedDiet) is an established healthy-eating behavior that ha...
The Author(s) 2015. This article is published with open access at Springerlink.com Background: World...
Background Hypertension is China’s leading cardiovascular disease risk factor. Improved hypertension...
Cost-effectiveness analysis of applying the Cholesterol and Recurrent Events (CARE) study protocol i...
<p>Objective: To estimate the economic efficiency of using pravastatin to prevent the transiti...
Objectives: To compare the cost-effectiveness ratios of sirolimus-eluting stents (SES) with bare-met...
textabstractIntroduction: Statin therapy reduces the rate of coronary heart disease, but high costs ...
pathic (individualized lifestyle counseling and nutritionalmedicine) approach to primary prevention ...
Background: Acute coronary syndrome (ACS) is defined as a “group of clinical symptoms compatible wit...
Background The Multi-Ethnic Study of Atherosclerosis (MESA) showed that the addition of coronary ar-...
Objectives: Patients presenting to hospital with acute, undifferentiated chest pain have a low, but ...
compared the effect of percutaneous coronary intervention (PCI) plus optimal medical therapy with op...
Unstable angina (UA) and non ST segment elevation myocardial infarction (NSTEMI) is one of common i...
Background: Cost-effectiveness is an increasingly important factor in the choice of a test or therap...
Background: Latin America has witnessed a marked increase in cardiovascular (CV) disease, the leadin...
Background: The Mediterranean-style diet (MedDiet) is an established healthy-eating behavior that ha...
The Author(s) 2015. This article is published with open access at Springerlink.com Background: World...
Background Hypertension is China’s leading cardiovascular disease risk factor. Improved hypertension...
Cost-effectiveness analysis of applying the Cholesterol and Recurrent Events (CARE) study protocol i...
<p>Objective: To estimate the economic efficiency of using pravastatin to prevent the transiti...
Objectives: To compare the cost-effectiveness ratios of sirolimus-eluting stents (SES) with bare-met...
textabstractIntroduction: Statin therapy reduces the rate of coronary heart disease, but high costs ...
pathic (individualized lifestyle counseling and nutritionalmedicine) approach to primary prevention ...
Background: Acute coronary syndrome (ACS) is defined as a “group of clinical symptoms compatible wit...
Background The Multi-Ethnic Study of Atherosclerosis (MESA) showed that the addition of coronary ar-...
Objectives: Patients presenting to hospital with acute, undifferentiated chest pain have a low, but ...
compared the effect of percutaneous coronary intervention (PCI) plus optimal medical therapy with op...
Unstable angina (UA) and non ST segment elevation myocardial infarction (NSTEMI) is one of common i...
Background: Cost-effectiveness is an increasingly important factor in the choice of a test or therap...
Background: Latin America has witnessed a marked increase in cardiovascular (CV) disease, the leadin...
Background: The Mediterranean-style diet (MedDiet) is an established healthy-eating behavior that ha...
The Author(s) 2015. This article is published with open access at Springerlink.com Background: World...
Background Hypertension is China’s leading cardiovascular disease risk factor. Improved hypertension...